FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway-Reference-Cited by-同舟云学术

FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway

Published:2020-02 Issue: Volume:470 Page:29-42
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Liu Chao,Zhao Yan,Wang Jianing,Yang Yan,Zhang Yan,Qu Xinliang,Peng Sishi,Yao Zhaoying,Zhao Shuli,He Bangshun,Mi Qiongyu,Zhu Yubing,Liu Xiuting,Zou Jianjun,Zhang Xu,Du Qianming

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Jiangsu Provincial Special Program of Medical Science

Sichuan Science and Technology Program

Natural Science Foundation of Chengdu Medical College

Innovation of medical research youth in Sichuan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference54 articles.

1. Targeted therapies in colorectal cancer-an integrative view by PPPM;Hagan;EPMA J.,2013

2. Global patterns and trends in colorectal cancer incidence and mortality;Arnold;Gut,2017

3. Colorectal cancer;Kuipers;Nat. Rev. Dis. Primers,2015

4. 5-Fluorouracil: mechanisms of resistance and reversal strategies;Zhang;Molecules,2008

5. Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations;Dominijanni;Cancer Drug Resist.,2018

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges;Frontiers in Immunology;2024-09-02

2. Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers;OncoTargets and Therapy;2024-08

3. Opposing Interplay between Nuclear Factor Erythroid 2-Related Factor 2 and Forkhead BoxO 1/3 is Responsible for Sepantronium Bromide’s Poor Efficacy and Resistance in Cancer cells: Opportunity for Combination Therapy in Triple Negative Breast Cancer;ACS Pharmacology & Translational Science;2024-04-29

4. Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases;Redox Biology;2024-04

5. α‐Hederin induces paraptosis by targeting GPCRs to activate Ca²⁺/MAPK signaling pathway in colorectal cancer;Cancer Medicine;2024-04